HomeAI · summaries
Storia in 3 fonti
In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
iodonna.it
umore del pancreas, il farmaco orale che apre una nuova speranza
Presentato all’ASCO, daraxonrasib ha mostrato risultati importanti nei pazienti con tumore del pancreas avanzato. Una possibile svolta, anche se l’arrivo in Europa richiederà tempo
- ·
forbes.com
In Fight Against Pancreatic Cancer, Daraxonrasib Is Rare Sign Of Hope
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.
- ·
dw.com
Pancreatic cancer: New drug extends lives but isn't a cure
The newly developed treatment daraxonrasib can double the years left to live for patients with pancreatic cancer — but it doesn't cure the disease and only works if the cancer is…